Clinuvel Pharmaceuticals Ltd (CUV) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.050x

Based on the latest financial reports, Clinuvel Pharmaceuticals Ltd (CUV) has a cash flow conversion efficiency ratio of 0.050x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$12.52 Million ≈ $8.86 Million USD) by net assets (AU$249.02 Million ≈ $176.19 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Clinuvel Pharmaceuticals Ltd (CUV) market capitalisation for the company's overall valuation and market capitalisation.

Clinuvel Pharmaceuticals Ltd - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Clinuvel Pharmaceuticals Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Clinuvel Pharmaceuticals Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Clinuvel Pharmaceuticals Ltd ranked by their cash flow conversion efficiency. Explore Clinuvel Pharmaceuticals Ltd (CUV) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Tianjin Hi-Tech Development Co Ltd SHG:600082	0.317x
ALPHA KLSE:0303	0.054x
PRUKSA HOLDING BK:PSH-R	0.035x
First Western Financial Inc NASDAQ:MYFW	0.043x
Gannett Co Inc NYSE:GCI	0.280x
Forafric Global PLC Ordinary Shares NASDAQ:AFRI	0.053x
Shanghai Huaming Intelligent Terminal Equipment Co Ltd SHE:300462	0.030x
Bohai Water Industry Co Ltd SHE:000605	0.008x

Annual Cash Flow Conversion Efficiency for Clinuvel Pharmaceuticals Ltd (2001–2025)

The table below shows the annual cash flow conversion efficiency of Clinuvel Pharmaceuticals Ltd from 2001 to 2025. View today's stock price for Clinuvel Pharmaceuticals Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$240.81 Million ≈ $170.39 Million	AU$41.10 Million ≈ $29.08 Million	0.171x	-6.50%
2024-06-30	AU$203.01 Million ≈ $143.64 Million	AU$37.05 Million ≈ $26.22 Million	0.183x	-18.59%
2023-06-30	AU$164.63 Million ≈ $116.49 Million	AU$36.91 Million ≈ $26.12 Million	0.224x	-29.40%
2022-06-30	AU$125.56 Million ≈ $88.84 Million	AU$39.87 Million ≈ $28.21 Million	0.318x	+62.78%
2021-06-30	AU$98.74 Million ≈ $69.86 Million	AU$19.26 Million ≈ $13.63 Million	0.195x	-0.91%
2020-06-30	AU$72.07 Million ≈ $50.99 Million	AU$14.19 Million ≈ $10.04 Million	0.197x	-39.00%
2019-06-30	AU$57.18 Million ≈ $40.46 Million	AU$18.46 Million ≈ $13.06 Million	0.323x	+8.80%
2018-06-30	AU$39.42 Million ≈ $27.89 Million	AU$11.69 Million ≈ $8.27 Million	0.297x	-23.88%
2017-06-30	AU$25.44 Million ≈ $18.00 Million	AU$9.92 Million ≈ $7.02 Million	0.390x	+238.00%
2016-06-30	AU$17.83 Million ≈ $12.62 Million	AU$-5.04 Million ≈ $-3.56 Million	-0.282x	+30.14%
2015-06-30	AU$11.21 Million ≈ $7.93 Million	AU$-4.53 Million ≈ $-3.21 Million	-0.404x	-29.70%
2014-06-30	AU$15.43 Million ≈ $10.92 Million	AU$-4.81 Million ≈ $-3.40 Million	-0.312x	+37.41%
2013-06-30	AU$13.84 Million ≈ $9.79 Million	AU$-6.89 Million ≈ $-4.88 Million	-0.498x	+32.24%
2012-06-30	AU$13.64 Million ≈ $9.65 Million	AU$-10.02 Million ≈ $-7.09 Million	-0.735x	-27.11%
2011-06-30	AU$16.41 Million ≈ $11.61 Million	AU$-9.49 Million ≈ $-6.71 Million	-0.578x	-29.67%
2010-06-30	AU$26.43 Million ≈ $18.70 Million	AU$-11.78 Million ≈ $-8.34 Million	-0.446x	-50.38%
2009-06-30	AU$37.05 Million ≈ $26.22 Million	AU$-10.99 Million ≈ $-7.77 Million	-0.296x	-113.93%
2008-06-30	AU$51.81 Million ≈ $36.66 Million	AU$-7.18 Million ≈ $-5.08 Million	-0.139x	-10.81%
2007-06-30	AU$65.39 Million ≈ $46.27 Million	AU$-8.18 Million ≈ $-5.79 Million	-0.125x	+84.66%
2006-06-30	AU$13.99 Million ≈ $9.90 Million	AU$-11.40 Million ≈ $-8.07 Million	-0.815x	+34.28%
2005-06-30	AU$7.45 Million ≈ $5.27 Million	AU$-9.25 Million ≈ $-6.54 Million	-1.240x	-82.98%
2004-06-30	AU$8.85 Million ≈ $6.27 Million	AU$-6.00 Million ≈ $-4.25 Million	-0.678x	-180.66%
2002-06-30	AU$10.31 Million ≈ $7.29 Million	AU$-2.49 Million ≈ $-1.76 Million	-0.242x	-531.42%
2001-06-30	AU$13.45 Million ≈ $9.52 Million	AU$-514.54K ≈ $-364.07K	-0.038x	--

About Clinuvel Pharmaceuticals Ltd

AU:CUV Australia Biotechnology

Market Cap

$298.65 Million

AU$422.08 Million AUD

Market Cap Rank

#14966 Global

#397 in Australia

Share Price

AU$8.37

Change (1 day)

+2.57%

52-Week Range

AU$8.01 - AU$13.23

All Time High

AU$44.55